INBS EFFECT: SEC filing
Intelligent Bio Solutions Inc.
Filed with the SEC on · accession 9999999995-26-003047
INBS filed a EFFECT (effect) with the SEC on Sep 23, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -1.7% by the first close after the filing.
Summary of the filing
Intelligent Bio Solutions Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.
Key details
How INBS stock reacted
Close before
$1.80
Sep 22, 2026
First close after
-1.67%
$1.77
5 trading days
-8.33%
$1.65
Since filing
+9.44%
$1.97
✦ Ask GOAX AI about this filing — what it means for INBS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INBS?
Click hereFrequently asked questions
What did INBS file with the SEC on Sep 23, 2026?
INBS filed a EFFECT (SEC filing). Intelligent Bio Solutions Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.
How do I read a EFFECT?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).
How did INBS stock react to this filing?
INBS closed at $1.80 before the filing and $1.77 on Sep 23, 2026 (-1.67%). Five trading days later: $1.65 (-8.33%).
Other INBS SEC filings
- DEF 14A · SEC filingNov 2, 2026
- 10-K/A · RestatementOct 21, 2026
- 8-K · SEC filingOct 13, 2026
- 424B3 · Secondary offeringSep 23, 2026
- S-3 · Shelf registrationSep 15, 2026
- 8-K · SEC filingSep 11, 2026
- 8-K · Fda approvalSep 9, 2026
- 8-K · Secondary offeringSep 2, 2026
- 8-K · Fda approvalSep 1, 2026
- 10-K · SEC filingAug 19, 2026
Get alerts when INBS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days